Dr. David Beach has 30+ years of experience working in the pharmaceutical industry and Heath Sciences area. He is the former President and CEO of TorPharm, the U.S. division of Apotex, Inc. He grew this company from a ‘greenfield start-up’ to over $400 million in revenue and 1,000+ employees during his decade long tenure as President.…

Read More

Mr. Lucking is currently Vice President of Regulatory Affairs, Quality Assurance and Clinical Research at ProSolus Pharmaceuticals. He was Executive Director of Regulatory Affairs, QA & QC for Hercon Pharmaceuticals, LLC from 2012-13. Prior to co-founding ABP in 2003, Mr. Lucking held various executive positions with Noven Pharmaceuticals, Inc from 1987-2003. His most recent position was as…

Read More

Mr. Goldfarb joined the company in December 2006 and has over thirty years of legal experience. Prior to joining ABP, from September 2005 until December 2006, Mr. Goldfarb was Senior Vice President, General Counsel and Secretary of Andrx Corporation.  Mr. Goldfarb joined Andrx in March of 2000, became Assistant General Counsel and in 2003 was appointed…

Read More

Dr. Hahn joined Accu-Break as Executive Chairman of the Board in 2004. Previously, he was co-founder and Chairman Emeritus of Andrx until its acquisition by Watson Pharmaceuticals, Inc. in November 2006. Dr. Hahn was President of Andrx from 1993 until 2003, served as Chairman of the Board from 2002-03 and as acting CEO from 2001-02. He…

Read More